1–2 of 2 results for Joel Pearlman
Preservation of Vision by ANX007: Clinical Results and Anatomic Changes From the Phase 2 ARCHER Trial
Joel Pearlman, MD, PhD
Annual Meeting Talks
2024
Retina-Owned ASCs
Updates from the Field